These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 15477414)

  • 1. Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice.
    Bursill CA; Choudhury RP; Ali Z; Greaves DR; Channon KM
    Circulation; 2004 Oct; 110(16):2460-6. PubMed ID: 15477414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice.
    Ali ZA; Bursill CA; Hu Y; Choudhury RP; Xu Q; Greaves DR; Channon KM
    Circulation; 2005 Aug; 112(9 Suppl):I235-41. PubMed ID: 16159823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral-mediated delivery of a viral chemokine binding protein blocks CC-chemokine activity in vitro and in vivo.
    Bursill CA; Cai S; Channon KM; Greaves DR
    Immunobiology; 2003; 207(3):187-96. PubMed ID: 12777060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.
    Park TS; Panek RL; Mueller SB; Hanselman JC; Rosebury WS; Robertson AW; Kindt EK; Homan R; Karathanasis SK; Rekhter MD
    Circulation; 2004 Nov; 110(22):3465-71. PubMed ID: 15545514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice.
    Alp NJ; McAteer MA; Khoo J; Choudhury RP; Channon KM
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):445-50. PubMed ID: 14707037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.
    Chi H; Messas E; Levine RA; Graves DT; Amar S
    Circulation; 2004 Sep; 110(12):1678-85. PubMed ID: 15353494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
    Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice.
    Mercer J; Figg N; Stoneman V; Braganza D; Bennett MR
    Circ Res; 2005 Apr; 96(6):667-74. PubMed ID: 15746445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
    Belalcazar LM; Merched A; Carr B; Oka K; Chen KH; Pastore L; Beaudet A; Chan L
    Circulation; 2003 Jun; 107(21):2726-32. PubMed ID: 12742997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis.
    Schieffer B; Selle T; Hilfiker A; Hilfiker-Kleiner D; Grote K; Tietge UJ; Trautwein C; Luchtefeld M; Schmittkamp C; Heeneman S; Daemen MJ; Drexler H
    Circulation; 2004 Nov; 110(22):3493-500. PubMed ID: 15557373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.
    Tsukamoto K; Tangirala RK; Chun S; Usher D; Puré E; Rader DJ
    Mol Ther; 2000 Feb; 1(2):189-94. PubMed ID: 10933930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes.
    Burnett MS; Durrani S; Stabile E; Saji M; Lee CW; Kinnaird TD; Hoffman EP; Epstein SE
    Circulation; 2004 Feb; 109(7):893-7. PubMed ID: 14757699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral gene transfer to reduce atherosclerosis progression by long-term CC-chemokine inhibition.
    Bursill CA; McNeill E; Wang L; Hibbitt OC; Wade-Martins R; Paterson DJ; Greaves DR; Channon KM
    Gene Ther; 2009 Jan; 16(1):93-102. PubMed ID: 18800153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis.
    Merched AJ; Chan L
    Circulation; 2004 Dec; 110(25):3830-41. PubMed ID: 15596565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of atherosclerosis in apolipoprotein-E-deficient mice following muscle transduction with adeno-associated virus vectors encoding human apolipoprotein-E.
    Harris JD; Schepelmann S; Athanasopoulos T; Graham IR; Stannard AK; Mohri Z; Hill V; Hassall DG; Owen JS; Dickson G
    Gene Ther; 2002 Jan; 9(1):21-9. PubMed ID: 11850719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal relationships between circulating levels of CC and CXC chemokines and developing atherosclerosis in apolipoprotein E*3 Leiden mice.
    Murphy N; Bruckdorfer KR; Grimsditch DC; Overend P; Vidgeon-Hart M; Groot PH; Benson GM; Graham A
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1615-20. PubMed ID: 12842836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient mice.
    Yoshioka T; Okada T; Maeda Y; Ikeda U; Shimpo M; Nomoto T; Takeuchi K; Nonaka-Sarukawa M; Ito T; Takahashi M; Matsushita T; Mizukami H; Hanazono Y; Kume A; Ookawara S; Kawano M; Ishibashi S; Shimada K; Ozawa K
    Gene Ther; 2004 Dec; 11(24):1772-9. PubMed ID: 15496963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
    Raffai RL; Loeb SM; Weisgraber KH
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
    Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
    Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.